Global /China /Healthcare /Drug Manufacturers - General /000590

Guhan Pharmaceutical Group Co., Ltd.

000590

• SHE: 000590 • Delayed

11.16CNY 0.5%

1.65 USD

As of 14 June 2026, Guhan Pharmaceutical Group Co., Ltd. has a market cap of $392.29M USD, ranking #16796 globally and #5242 in China. It ranks #1518 in the Healthcare sector, and #553 in the Drug Manufacturers - General industry.

Global Rank

16796

Country Rank

5242

Sector Rank

1518

Industry Rank

553

Key Stats

Market Cap

$392.29MUSD

2.66B CNY

Enterprise Value

$381.91MUSD

2.58B CNY

Revenue (TTM)

$50.79MUSD

344.12M CNY

EBITDA (TTM)

$1.74MUSD

11.8M CNY

Net Income (TTM)

-$6.06MUSD

-41.07M CNY

EBITDA Margin

3.4%

Profit Margin

-12%

PS Ratio

7.7

PB Ratio

4.9

EV/EBITDA

177.3

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Xue Feng open_in_new

Employees

1,064

Founded

1956

Website

guhan.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.5%	1.3%	-7.7%	-3.8%	-9.9%	-1%	28%	29%	33%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	000590 启迪药业集团股份公司 Class A ISIN: CNE000000701 Shares Out.: Shares Outstanding: 239.471M¹ Shares Float: 172.41M² TV: TradingView: SZSE: 000590 SA: Stock Analysis: SHE: 000590 YF: Yahoo Finance: 000590.SZ GF: Google Finance: SHE: 000590 BA: Barron's: 000590 MS: Morningstar: XSHE: 000590	11.16 CNY	TV: TradingView: SZSE: 000590 SA: Stock Analysis: SHE: 000590 YF: Yahoo Finance: 000590.SZ GF: Google Finance: SHE: 000590 BA: Barron's: 000590 MS: Morningstar: XSHE: 000590

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Guhan Pharmaceutical Group Co., Ltd.

Guhan Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells traditional Chinese medicines, chemical drugs, and health food under the Guhan brand in China. It operates through the Pharmaceutical and Health Product Manufacturing and Sales Business, Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business, and Other Business segments. The company offers prescription and over-the-counter drugs, such as tonics, cardiovascular drugs, children's nutritional supplements, cold and flu remedies, and heat-clearing and detoxifying drugs. It also engages in nutrition and health consulting services; Chinese herbal medicine cultivation; medical research and experimental development; cultural and artistic exchange planning; medical consultation; internet sales; technology promotion, consulting, and agency services; outpatient services; and pharmaceutical wholesale and retail activities. The company was formerly known as Tus-Pharmaceutical Group Co., Ltd. and changed its name to Guhan Pharmaceutical Group Co., Ltd. in November 2025. Guhan Pharmaceutical Group Co., Ltd. was founded in 1956 and is headquartered in Hengyang, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 14K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 13K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 7K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 5K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 4K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 4K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 194K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 139K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 92K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 82K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 74K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 70K%	20.5	Switzerland

chevron_leftBack